The UK Heath Security Agency (UKHSA) published Technical Briefing #3 yesterday, summarizing the ongoing investigations into the unusual rates of acute liver inflammation (hepatitis) with unknown etiology in children.
The UKHSA’s document issued on May 20, 2022, reviews the clinical outcomes for 197 pediatric cases, most living in England. One hundred and eighty of these children were hospitalized, of whom 11 required liver transplantation.
And the usual viruses that cause infectious hepatitis (hepatitis A to E) have not been detected.
11 Liver Transplants in UK Children After Mysterious Inflammation
CDC Advisers Recommend Pfizer Booster Shot for Children 5 to 11
Third shot can be given at least five months after healthy children complete the two-dose vaccine series
Psychological Distress May Increase Risk for COVID-19 Hospitalization
Depression, worry about COVID-19, loneliness as strongly linked to hospitalization as high cholesterol, hypertension
Rollout of Pfizer COVID-19 Vaccine Saved Lives, Health Care Dollars
Model shows vaccine tied to prevention of 110,000 deaths and a resulting $30.4 billion direct health care cost savings
Preexisting Cardiovascular Conditions Tied to Severe COVID-19 in Children
Risk varies considerably across 26 examined cardiovascular conditions
U.S. Hospitals Facing Shortage of Dye Needed for Life-Saving Scans
Shortage expected to last until at least June 30, according to the American Hospital Association
Loss of Smell, Taste Less Likely With Newer COVID-19 Variants
Lower risk for developing chemosensory loss observed with alpha, delta, and omicron variants
Increasing Impact of HPV Vaccination Seen in the United States
Impact on 4vHPV-type prevalence in 2015 to 2018 for 14- to 24-year-old females 90 percent among vaccinated, 74 percent among unvaccinated
FDA Authorizes Pfizer Booster Shot for Children Ages 5 to 11 Years
Third shot can be given at least five months after healthy children complete the two-dose vaccine series